Utah Medical Products Inc. (UTMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Utah Medical Products Inc. (UTMD:NASDAQ), powered by AI.

Current Price
$67.47
P/E Ratio
19.0
Market Cap
215M
Sector
Healthcare
What is the Utah Medical Products Inc. stock price forecast?

Utah Medical Products Inc. is currently trading at $67.47. View real-time AI analysis on Alpha Lenz.

What is Utah Medical Products Inc. insider trading activity?

View the latest insider trading data for Utah Medical Products Inc. on Alpha Lenz.

What is Utah Medical Products Inc.'s P/E ratio?

Utah Medical Products Inc.'s P/E ratio is 19.0.

Utah Medical Products Inc.

NASDAQ · UTMD
$67.47-2.40(-3.43%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Utah Medical Products Inc.'s future dividend policy...
Alpha Chat Insight

Utah Medical Products Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 9.5%. Operating margin of 29.6% indicates strong profitability.

Ask for details

Company Overview

Utah Medical Products Inc. is a company that specializes in manufacturing and distributing a diverse range of medical devices. Its core products cater primarily to critical care areas such as neonatal care, obstetrics, gynecology, and general surgery. The company's products include catheters, blood pressure monitoring kits, and specialized devices used in the labor and delivery rooms, which are crucial in providing optimal patient care during childbirth. Utah Medical Products serves a wide variety of healthcare facilities, including hospitals and outpatient clinics, underscoring its integral role in the medical supply chain. Established in 1978 and headquartered in Utah, USA, the company not only meets the needs of the domestic market but also extends its reach internationally. In the financial markets, Utah Medical Products Inc. is recognized for its consistent delivery of high-quality medical products that are essential in everyday healthcare operations, contributing significantly to the industry’s innovation and efficiency. This positions the company as an important player in the medical device sector, with a robust reputation built on reliability and performance.

CEOMr. Kevin L. Cornwell
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees155

Company Statistics

FY 2025

Profile

$214.97MMarket Cap
$38.52MRevenue
0.00Shares Out
155Employees

Margins

57.12%Gross
30.12%EBITDA
29.60%Operating
36.63%Pre-Tax
29.30%Net

Valuation

19.05P/E
1.80P/B
5.58EV/Sales
11.16EV/EBITDA
15.01P/FCF

Growth (CAGR)

-9.68%Rev 3Yr
-1.80%Rev 5Yr
-16.79%Op Inc 3Yr
-3.62%Op Inc 5Yr
-11.84%Net Inc 3Yr
0.89%Net Inc 5Yr

Returns

9.21%ROA
9.54%ROE
9.30%ROIC

Financial Health

$85.76MCash & Cash Equivalents
$-82.48MNet Debt
2.75%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Utah Medical Products Inc. (ticker: UTMD) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 155 employees. Market cap is $215M.

The current price is $67.47 with a P/E ratio of 19.05x and P/B of 1.8x.

ROE is 9.54% and operating margin is 29.60%. Annual revenue is $39M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Utah Medical Products Inc. (UTMD) Stock Forecast 2026 $67.47 — Price, Financials & Analyst Targets | Alpha Lenz